Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07805512) titled 'A Study to Evaluate the Effectiveness and Safety of Restylane Shaype in the Improvement of Jawline Definition' on Sept. 1.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).
Primary Sponsor: Galderma R&D
Condition:
Jawline Definition
Intervention:
Device: Restylane Shaype
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: September 2026
Target Sample Size: 162
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/study/NCT07805512
Discl...